Drostanolone Propionate by Genesis is a pharmaceutical-grade androgenic anabolic steroid (AAS) formulated at 100 mg/ml in a multidose 10ml vial. Widely recognized in competitive bodybuilding and elite athletics under the trade name Masteron, drostanolone is a 2-methylated derivative of dihydrotestosterone (DHT). The introduction of a methyl group at the carbon 2 position shields the hormone from metabolic deactivation by the 3-hydroxysteroid dehydrogenase enzyme within skeletal muscle tissue, providing pronounced anabolic activity while retaining pure DHT properties.
Because it is inherently non-aromatizing, drostanolone acts as a mild anti-estrogen by interacting with aromatase enzymes and competing for estrogen receptor sites. Athletes looking to achieve ultimate conditioning, striated muscle hardness, and vascularity consistently choose Masteron Propionate during contest preparation and caloric deficit phases.
Drostanolone propionate targets androgen receptors with high binding affinity, directly stimulating lipolysis via adrenergic mechanisms in adipose tissue while enhancing nitrogen retention and cellular protein synthesis. Free from estrogenic conversion, it causes zero subcutaneous fluid retention, delivering a dense, chiseled, and granite-like muscle aesthetic.
The short propionate ester requires frequent intramuscular injections into deep muscle tissue such as the gluteal region, ventrogluteal site, or deltoids to maintain steady blood plasma levels.
Drostanolone Propionate by Genesis synergizes exceptionally well with non-aromatizing compounds such as Winstrol (Stanozolol), Trenbolone Acetate, or Primobolan, alongside a base of Testosterone Propionate to preserve essential physiological functions. Its mild anti-estrogenic behavior frequently reduces the need for high doses of ancillary aromatase inhibitors in moderately dosed cutting stacks.
Despite low progestogenic and non-existent estrogenic pathways, drostanolone exerts negative feedback on the hypothalamic-pituitary-gonadal axis (HPGA), suppressing endogenous testosterone synthesis. A structured Post-Cycle Therapy protocol with selective estrogen receptor modulators (SERMs) like Tamoxifen (Nolvadex) and Clomiphene (Clomid) is critical beginning 3 to 4 days after the last injection. Routine lipid panels (HDL/LDL balance) and blood pressure monitoring are recommended throughout the cycle.
Due to the propionate ester's half-life of approximately 2.5 days, drostanolone propionate is best administered via intramuscular injection every other day (EOD) to avoid hormone level fluctuations and injection site discomfort.
No. Drostanolone is derived from DHT and cannot aromatize into estrogen. It causes zero water retention and actually displays mild anti-estrogenic properties that help mitigate estrogen-related side effects in multi-compound cycles.
While chemically capable of supporting lean tissue gains, its low anabolic rating makes it suboptimal for raw mass bulking. It is primarily engineered for cutting, vascular enhancement, and competition hardening.
